🇺🇸 Cattle Encephalon Glycoside and Ignotin in United States
6 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 6
Most-reported reactions
- Gingival Bleeding — 2 reports (33.33%)
- Thrombotic Thrombocytopenic Purpura — 2 reports (33.33%)
- Circulatory Collapse — 1 report (16.67%)
- Respiratory Failure — 1 report (16.67%)
Other Neurology approved in United States
Frequently asked questions
Is Cattle Encephalon Glycoside and Ignotin approved in United States?
Cattle Encephalon Glycoside and Ignotin does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Cattle Encephalon Glycoside and Ignotin in United States?
Rong Hu, MD is the originator. The local marketing authorisation holder may differ — check the official source linked above.